Stephane Angers

Byu Ri Sim is the winner of the 2026 Jennifer Comyn Graduate Award for Cancer Research! Byu Ri is investigating how the hyperactive pathway signalling behind colorectal cancer cells can be exploited to identify new therapeutic avenues. Read more here: thedonnellycentre.utoronto.ca/news/2026-jenn…

We are looking to hire a Financial Administrator! Our financial team provides a wide range of analysis, reporting, and administration, as they oversee the building's research grants, financial statements, discrepancies, and financial reports. Learn more: jobs.utoronto.ca/job/Toronto-Fi…

Congratulations to Donnelly PI Gary Bader, for receiving a Connaught Innovation Award! Read about all the 2025-26 Connaught Innovation Award winners in U of T Celebrates: utoronto.ca/celebrates/14-…

Leveraging synthetic antibodies and single-molecule microscopy, scientists interrogate how #Wnt ligands may induce different downstream responses depending on which coreceptors are recruited to the Wnt receptor Frizzled. @StephAngers @uoftmedicine scim.ag/4e30J00

A video showing Carney and Poilievre going at it in the House of Commons today is going viral 😂

Leveraging synthetic antibodies and single-molecule microscopy, scientists interrogate how #Wnt ligands may induce different downstream responses depending on which coreceptors are recruited to the Wnt receptor Frizzled. @StephAngers @uoftmedicine scim.ag/4e30J00

A two-step mechanism may shape how Wnt ligands induce different intracellular responses depending on which coreceptor interacts with #Frizzled—a discovery that could inform research into selective modulators of the Wnt pathway. @StephAngers @uoftmedicine scim.ag/4e30J00

When faced with a mountain of gene expression data, reducing the computational complexity for analyzing a cell’s RNA transcripts is an invaluable development. Read about how our researchers accomplished it in our latest piece by Donnelly News: thedonnellycentre.utoronto.ca/news/bader-lab…

Our 2025 Annual Report is now available! This magazine-style report showcases our most popular research stories and news highlights, in addition to covering a breakdown of our faculty, students, awards, and funding. Read the 2025 Annual Report now: thedonnellycentre.utoronto.ca/news/donnelly-…

Society of Gynecologic Oncology warns of fast-rising incidence of cervical cancer in Canadian women, even as other countries are on the verge of eliminating the disease through HPV vaccination. Canada rate of vax only 64%.

The Donnelly Centre is hiring a new Research and Communications Officer! As a vital part of our administration team, this role covers the external and internal communications of our community. Learn more about the role and apply at the link below: jobs.utoronto.ca/job/Toronto-Re…

Research can take many forms. As a part of our 20th Anniversary Retrospective series, we sat down with Donnelly PI Mikko Taipale, to talk about his 2020 paper “An efficient KRAB domain for CRISPRi applications in human cells” Read the full story here: thedonnellycentre.utoronto.ca/news/how-sidet…

Today we're highlighting the research of Donnelly's newest faculty member, Ashley Libby! Read about Libby's work in our most recent story: thedonnellycentre.utoronto.ca/news/chicken-s…

Please give a warm welcome to Donnelly's newest faculty member, Dr. Ashley Libby! Learn why she was drawn to the domesticated chicken as a system model, and discover the research the Libby Lab will be tackling at the Donnelly in our most recent story: thedonnellycentre.utoronto.ca/news/chicken-s…

@ChristineAllenW Merry Christmas to you guys!

Merry Christmas from our family to yours. Wishing everyone a restful holiday break.

When the first draft sequence of the human genome was published in 2001, scientists began to redirect their research questions to better reflect new understandings. Among them was Ben Blencowe, PI at the Donnelly Centre. Full story available here: thedonnellycentre.utoronto.ca/news/benjamin-…

Day 6 of Hope 🕊 Submitted By: Dr. @StephAngers,  Professor and Director Charles H. Best Chair of Medical Research, @DonnellyCentre for Cellular + Biomolecular Research, @uoftmedicine @UofT “It is an exciting time for biomedical research with access to new powerful genomic technologies that are allowing us to systematically probe the importance of every human gene for the development and progression of various brain tumours. We are moving beyond standard approaches toward a new era of precision oncology.  Research matters because it is the only vehicle for transforming a diagnosis with limited options into one with manageable outcomes. Innovation is the difference between stalling the disease and curing it. New innovations and supporting discovery research is the only way that will enable breakthrough treatments for incurable brain tumours. This is where the mission of  Brain Cancer Canada is vital: it serves as a distinct bridge to hope by funding the high-reward, translational science that others may deem too risky. By connecting donors directly to the labs where miracles are engineered, we ensure that funding gaps do not become stopping points. Brain Cancer Canada is a catalyst to support new innovative research to better understand these diseases and spark the development of new treatment strategies.” #12DaysofHope #DrAngers #BrainCancer #BrainTumour

Today we're highlighting Gary Bader, who we recently interviewed for our 20-Year Anniversary retrospective series. Read the full story below: thedonnellycentre.utoronto.ca/news/power-dat…

The HPV vaccine is miraculous. Look at the green line of cervical cancer rates:

ZERO cases of cervical cancer diagnosed in women under age 25 in Australia 🇦🇺 None . Nada . Zip. For the first time since records began! How did this happen? One word VACCINES!!!!!